THC: "transitional drug' for emesis therapy?
Macek, C.
JAMA 247(19): 2648-2650; 2655
1982
ISSN/ISBN: 0098-7484 PMID: 6281484 Document Number: 184468
Document emailed within 1 workday
Related Documents
Yamada, T.; Tanaka, N.; Yokoi, K.; Ishikawa, N.; Seya, T.; Horiba, K.; Kanazawa, Y.; Shirakawa, T.; Ohkawa, K.; Kudoh, H.; Koizumi, M.; Yoshioka, M.; Tajiri, T. 2007: Substance P and anticancer drug-induced emesis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(6): 903-906Stewart, J.J.; Weisbrodt, N.W.; Burks, T.F. 1976: Changes in the myoelectric activity of the small intestine associated with drug-induced emesis in the conscious cat Proceedings of the Western Pharmacology Society 19: 439-444
Joss, R.A.; Brand, B.C.; Buser, K.S.; Cerny, T. 1990: The symptomatic control of cytostatic drug-induced emesis. a recent history and review European Journal of Cancer 26(Suppl 1): S2-S8
Blower, P.R. 1990: The role of specific 5-HT3 receptor antagonism in the control of cytostatic drug-induced emesis European Journal of Cancer 26(Suppl 1): S8-11
Bouffioux, C. 1985: Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given? Progress in Clinical and Biological Research 185b: 47-55
Ball, A.L.; Rana, S.; Dehne, K.L. 1998: HIV prevention among injecting drug users: responses in developing and transitional countries Public Health Reports 113 Suppl. 1: 170-181
Roy, E.P.; Corey, A.L.; Marano, G.D.; Hogan, T.F. 1987: CNS drug sanctuary effect. Spinal cord metastasis in transitional cell carcinoma West Virginia Medical Journal 83(9): 430-431
Avritscher, E.B.C.; Shih, Y-Chen.T.; Sun, C.C.; Gralla, R.J.; Grunberg, S.M.; Xu, Y.; Elting, L.S. 2010: Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients Journal of Supportive Oncology 8(6): 242-251
Vergin, H.; Köhler, M.; Senn, H.J. 1984: Metoclopramide plasma levels following oral administration of high doses for prophylaxis of emesis in cytostatic therapy Arzneimittel-Forschung 34(11): 1595-1597
Mori, H.; Miyaji, B.; Takahashi, M.; Matsuda, K.; Tsuka, H.; Wada, O.; Aoki, Y.; Akino, H.; Muranaka, K.; Kanamaru, H.; Okada, K.; Imamura, Y. 1996: Intracavitary bacillus Calmette-Guerin therapy for upper tract transitional cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 42(4): 257-261
Oehme, P.; Brüschke, G.; Kluchert, K.; Krüger, U. 1970: Current problems of drug therapy. 9. Stationary and ambulatory drug therapy. 2 Das Deutsche Gesundheitswesen 25(21): 957-960
Momose, H.; Arai, K.; Nakagawa, Y.; Fujimoto, K.; Tsujimoto, S.; Cho, M.; Tani, Y.; Saka, M.; Nakatsuji, F.; Iwai, A. 1989: Neoadjuvant chemoradiotherapy in locally invasive transitional cell carcinoma of the urinary bladder: early results of PVB and CAP therapy Hinyokika Kiyo. Acta Urologica Japonica 35(5): 781-788
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645
Ao, T.; Endo, T.; Shiokawa, H.; Shimura, S.; Adachi, K.; Koshiba, K. 1993: Kidney-conservative surgery followed by bacillus Calmette-Guerin instillation therapy for transitional cell carcinoma of solitary renal pelvis: a case report Hinyokika Kiyo. Acta Urologica Japonica 39(5): 463-465
Iimori, M. 2005: Psychotherapy and drug therapy--drug therapy within the framework of psychotherapy and psychotherapy conducted during drug therapy Seishin Shinkeigaku Zasshi 107(5): 500-505
Vozeh, S. 1984: Drug level determination for optimization of drug therapy. Practical significance and new trends Schweizerische Rundschau für Medizin Praxis 73(49): 1505-1506
Fujii, Y. 2001: Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia Seishin Shinkeigaku Zasshi 103(12): 1030-1035
Bunton, R.W. 1983: Reintroduction of anti-inflammatory drug therapy after drug-associated gastrointestinal disturbances New Zealand Medical Journal 96(726): 144
Ishihara, H. 2011: Treatment for exacerbation--drug and non-drug therapy, criteria of hospitalization and ICU admission Nihon Rinsho. Japanese Journal of Clinical Medicine 69(10): 1863-1868
Lerch, C. 1994: Responsibility for patient education in drug therapy from the viewpoint of the drug industry Zeitschrift für Arztliche Fortbildung 88(12): 1055-1060